Using CRP‐based cachexia as a reference, only the IBI‐based cachexia definition demonstrated positive clinical benefits (HR: 0.003, 95% CI: 0.005–0.006, P = 0.024) (Table 4). The gene discussed is CRP; the disease is Cachexia.